Concepedia

Rodney A. Beck

RA

8

Publications

469

Citations

8

H-Index

2008

Active since

Affiliations

Clearview Cancer Institute(Current)

University of Rochester

ID Genomics (United States)

Rodney A. Beck is an author at Clearview Cancer Institute specializing in pathology, cancer research, and oncology.

Top concepts

Publications per year

2008–2012

8

Publications

8

Mammostrat®as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy

John M.S. Bartlett, Jeremy Thomas, Douglas T. Ross et al. · Breast Cancer Research · 2010 · 118 citations · Full text

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma

Brian Z. Ring, Robert S. Seitz, Rodney A. Beck et al. · Modern Pathology · 2009 · 91 citations · Full text

, , +8

Mammostrat As an Immunohistochemical Multigene Assay for Prediction of Early Relapse Risk in the Tamoxifen Versus Exemestane Adjuvant Multicenter Trial Pathology Study

John M.S. Bartlett, Kenneth J. Bloom, Tammy Piper et al. · Journal of Clinical Oncology · 2012 · 65 citations · Full text

Chemosensitivity and Stratification by a Five Monoclonal Antibody Immunohistochemistry Test in the NSABP B14 and B20 Trials

Douglas T. Ross, Chung-yeul Kim, Gong Tang et al. · Clinical Cancer Research · 2008 · 65 citations · Full text

The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence

David G. Hicks, Bagi R. Janarthanan, Ramya Vardarajan et al. · BMC Cancer · 2010 · 38 citations · Full text

Rows per page

1–5 of 8